Literature DB >> 21893022

Whole cell microtubule analysis by flow cytometry.

Karen C Morrison1, Paul J Hergenrother.   

Abstract

Perturbation of the tubulin/microtubule dynamic in cells is perhaps the single most important mode of action of anticancer drugs. Standard methods for identifying and evaluating compounds for their ability to alter tubulin polymerization are low throughput, labor intensive, expensive, or make their assessment in vitro. Here we report a method to rapidly quantify the extent of tubulin polymerization in whole cells using flow cytometry, and we use this technique to evaluate compounds that stabilize and destabilize microtubule formation. This facile method is useful for conveniently, quantitatively, and cost-effectively comparing small molecules that perturb tubulin polymerization.
Copyright © 2011 Elsevier Inc. All rights reserved.

Mesh:

Substances:

Year:  2011        PMID: 21893022     DOI: 10.1016/j.ab.2011.08.020

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  15 in total

1.  Mitotic Exit Dysfunction through the Deregulation of APC/C Characterizes Cisplatin-Resistant State in Epithelial Ovarian Cancer.

Authors:  Anil Belur Nagaraj; Olga Kovalenko; Rita Avelar; Peronne Joseph; Annalyn Brown; Arshia Surti; Sandra Mantilla; Analisa DiFeo
Journal:  Clin Cancer Res       Date:  2018-04-13       Impact factor: 12.531

2.  Novel piperazine-based compounds inhibit microtubule dynamics and sensitize colon cancer cells to tumor necrosis factor-induced apoptosis.

Authors:  Avijeet Chopra; Amy Anderson; Charles Giardina
Journal:  J Biol Chem       Date:  2013-12-12       Impact factor: 5.157

3.  6-MOMIPP, a novel brain-penetrant anti-mitotic indolyl-chalcone, inhibits glioblastoma growth and viability.

Authors:  Shengnan Du; Jeffrey G Sarver; Christopher J Trabbic; Paul W Erhardt; Allen Schroering; William A Maltese
Journal:  Cancer Chemother Pharmacol       Date:  2018-11-13       Impact factor: 3.333

4.  Cytochrome P450 1B1 (CYP1B1) polymorphisms are associated with clinical outcome of docetaxel in non-small cell lung cancer (NSCLC) patients.

Authors:  Enrico Vasile; Carmelo Tibaldi; G Leticia Leon; Armida D'Incecco; Elisa Giovannetti
Journal:  J Cancer Res Clin Oncol       Date:  2014-12-14       Impact factor: 4.553

5.  SKI-178: A Multitargeted Inhibitor of Sphingosine Kinase and Microtubule Dynamics Demonstrating Therapeutic Efficacy in Acute Myeloid Leukemia Models.

Authors:  Jeremy A Hengst; Taryn E Dick; Arati Sharma; Kenichiro Doi; Shailaja Hegde; Su-Fern Tan; Laura M Geffert; Todd E Fox; Arun K Sharma; Dhimant Desai; Shantu Amin; Mark Kester; Thomas P Loughran; Robert F Paulson; David F Claxton; Hong-Gang Wang; Jong K Yun
Journal:  Cancer Transl Med       Date:  2017-08-14

6.  RSK2 signals through stathmin to promote microtubule dynamics and tumor metastasis.

Authors:  G N Alesi; L Jin; D Li; K R Magliocca; Y Kang; Z G Chen; D M Shin; F R Khuri; S Kang
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

7.  A cell-based pharmacokinetics assay for evaluating tubulin-binding drugs.

Authors:  Yuwei Wang; Jihua Liu; Jun Zhang; Liping Wang; Jonathon Chan; Hai Wang; Yi Jin; Lei Yu; David W Grainger; Wenbin Ying
Journal:  Int J Med Sci       Date:  2014-03-18       Impact factor: 3.738

8.  A cellular genome-wide association study reveals human variation in microtubule stability and a role in inflammatory cell death.

Authors:  Raul E Salinas; Cassandra Ogohara; Monica I Thomas; Kajal P Shukla; Samuel I Miller; Dennis C Ko
Journal:  Mol Biol Cell       Date:  2013-10-30       Impact factor: 4.138

9.  Stathmin 1/2-triggered microtubule loss mediates Golgi fragmentation in mutant SOD1 motor neurons.

Authors:  Sarah Bellouze; Gilbert Baillat; Dorothée Buttigieg; Pierre de la Grange; Catherine Rabouille; Georg Haase
Journal:  Mol Neurodegener       Date:  2016-06-09       Impact factor: 14.195

10.  Activity of BKM120 and BEZ235 against Lymphoma Cells.

Authors:  Monica Civallero; Maria Cosenza; Samantha Pozzi; Alessia Bari; Paola Ferri; Stefano Sacchi
Journal:  Biomed Res Int       Date:  2015-10-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.